Effect of eicosapentaenoic acid administration on apnea hypopnea index in sleep apnea patients who underwent percutaneous coronary interventio
Not Applicable
Recruiting
- Conditions
- Sleep apnea
- Registration Number
- JPRN-UMIN000019318
- Lead Sponsor
- ishiarai Heart Center Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
(i) Patients who are already administered eicosapentaenoic acid at the time of polysomnography (ii) Patients with allergic reaction against eicosapentaenoic acid (iii) Patients with malignant neoplasm with life expectancy <6 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Apnea hypopnea index (comparison between before and 6 months after administration)
- Secondary Outcome Measures
Name Time Method (i) Fatty acid fraction, lipid profiles (ii) Intima-media thickness of carotid artery (iii) Cardiac functions on transthoracic echocardiography (iv) Flow-mediated dilation (FMD) (v) Neurohumoral factors (plasma renin activity, plasma aldosterone concentration, catecholamines, brain natriuretic peptide (BNP)) (vi) Systemic blood pressure, heart rate (vii) Cardiothoracic ratio (viii) Adverse cardiovascular event rate